Table 5.

A summary of external structure-controlled noble metal nanoparticles based LFIA.

Structure	Analyte	Dynamic range	LOD	Ref.
Core-shell	Phenylethanolamine A	No given	0.32 pg mL-1	173
	Salbutamol	No given	3.0 pg mL-1	169
	Salmonella enteritidis	2.7-2.7×106 CFU mL-1	27 CFU mL-1	174
	Respiratory infection virus	1 pM-50 nM	0.03-0.041 pM	193
	Pseudorabies virus	41-650 ng mL-1	5 ng mL-1	175
	Pharmaceutical diclofenac	No given	0.07 pg mL-1	194
	Clenbuterol	0-1 ng mL-1	5 ng mL-1	171
	Myoglobin	0.01-500 ng mL-1	3.2 pg mL-1	22
	Cardiac troponin I	0.01-50 ng mL-1	0.44 pg mL-1
	Creatine kinase-MB isoenzymes	0.02-90 ng mL-1	0.55 pg mL-1
	Cardiac troponin I	No given	0.1 ng mL-1	149
	Mycoplasma pneumoniae (IgM)	0.1 ng -10 μg mL-1	0.1 ng mL-1	176
	Mycoplasma pneumoniae	0.1-10 mg mL-1	0.1 ng mL-1
	Cardiac troponin I	0.09-50 ng mL-1	0.09 ng mL-1	158
Core-statellite	Aflatoxin B2	No given	0.9 ng mL-1	153
	rabbit IgG	0.05-2 ng mL-1	0.01 ng mL-1	154
	HCG	No given	0.039 mIU mL-1	163
	MicroRNA	No given	10 pM	164
	HCG	No given	1.6 mIU mL-1	166
	Clenbuterol	0.1-2 ng mL-1	0.1 ng mL-1	157
	C-reactive protein	No given	0.08 ng mL-1	165
	Influenza A	No given	2.5×10-2 HAU mL-1	150
	17β-estradiol	No given	0.5 ng mL-1	155
Nanoaggregates	HIV-1	No given	0.1 nM	151
	Nucleoside	No given	20 µM	195
	p24 antigen	0.1 fg mL-1-10 ng mL-1	0.01 fg mL-1	162
	Methamphetamine	0.023-375 ng mL-1	0.026 ng mL-1	161
	HCG	0.49-1000 mIU mL-1	0.49 mIU mL-1	82
	Hepatitis B surface antigen	0.46-1000 ng mL-1	0.45 ng mL-1
	Troid-stimulating hormone	0.4-40 μIU mL-1	0.5 μIU mL-1	196